Illumina Reports Win in FTC Challenge to Grail Acquisition
- September 02, 2022
An administrative law judge (ALJ) has ruled in favor of Illumina Inc. in the Federal Trade Commission’s (FTC's) challenge to the genetic sequencing firm’s now-completed acquisition of cancer detection company Grail, Illumina announced September 1.
ARTICLE TAGS
You must be logged in to access this content.